Supply and procurement

1 The GAVI Alliance Vaccine Supply and Procurement Strategy for the period 2011-2015 VERSION NUMBER APPROVAL PROCESS DATE 1.0 Reviewed by: GAVI Programme and Policy Committee 28 September 2011 Approved by: GAVI Alliance Board 17 November 2011 Effective from: approval date Review: in 2014, in preparation for the develop

HPV Supply and Procurement Roadmap www.gavialliance.org UPDATE 2012 1 PUBLIC SUMMARY Supply and Procurement Roadmap HPV (Human Papilloma Virus) Vaccine The market-shaping goal Shape vaccine markets to provide appropriate and affordable vaccines HPV Supply and Procurement Roadmap www.gavialliance.org UPDATE 2012 2 The G

In July 2011 the GAVI Secretariat launched a public consultation process on the draft Vaccine Supply and Procurement Strategy for 2011-2015. The consultation was open from 4 to 29 July 2011. This document provides an overview of the process, as well as a summary of the main themes that emerged from the comments received.

In order to achieve its market shaping objectives, GAVI is redesigning its vaccine supply and procurement strategy. This document outlines the objectives and strategies, and describes the supply and procurement mechanisms by which the new strategy will be effected.

This document provides background information to GAVI's Draft Vaccine Supply and Procurement Strategy for the period 2011-2015, made available for public consultation.

GAVI recognizes immunisation as an important and potentially cost-effective intervention that can enhance the right of all children to a healthy life, that has positive effects in combating poverty and that is a critical contribution to the achievement of public health gains.

Recommendations and analysis of the GAVI supply strategy task team for a supply and procurement stragety for Hib and HebB containing vaccines during the GAVI Board meeting, 6-7 December 2005, in Delhi, India.

Summary of the findings of a study commissioned by the Vaccine Fund and the GAVI FInancing Task Force Procurement Sub-group to examine the first procurement of vaccines by GAVI and the Vaccine Fund.